Granules India gets USFDA nod for generic product

Granules India gets USFDA nod for generic product

By, Admin 31 January 2022

he US Food & Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) for Potassium Chloride for Oral Solution filed by Granules Pharmaceuticals Inc (GPI), a wholly-owned foreign subsidiary of the company. Drug firm Granules India on Friday said it has received approval from the US health regulator to market Potassium Chloride, which is used to treat low blood levels. The US Food & Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) for Potassium Chloride for Oral Solution filed by Granules Pharmaceuticals Inc (GPI), a wholly-owned foreign subsidiary of the company. Potassium Chloride is used to prevent or to treat low blood potassium levels hypokalemia. The product would be available for the US market shortly, Granules India said in a statement. "We are pleased to receive the approval of the product and will surely be a valuable addition to our growing product portfolio in the US market," GPI Executive Director Priyanka Chigurupati noted. Granules stated that it now has a total of 49 ANDA approvals from the USFDA. According to MAT Nov 2021, IQVIA/IMS Health data, the current annual US market for Potassium Chloride for Oral Solution is around USD 44 million.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!